Cantor Fitzgerald Initiates Coverage on Amgen (NASDAQ:AMGN)
Stock analysts at Cantor Fitzgerald began coverage on shares of Amgen (NASDAQ:AMGN – Get Free Report) in a note issued to investors on Tuesday, Marketbeat.com reports. The firm set a “neutral” rating and a $305.00 price target on the medical research company’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 9.75% from the […]
Stock analysts at Cantor Fitzgerald began coverage on shares of Amgen (NASDAQ:AMGN – Get Free Report) in a note issued to investors on Tuesday, Marketbeat.com reports. The firm set a “neutral” rating and a $305.00 price target on the medical research company’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 9.75% from the […]
